公司資料
Puma Biotechnology Inc 股價、新聞與催化劑
- 股票代碼:
- PBYI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
8.82 USD (-0.11%)
收盤價
最後更新: 2026年8月17日
355M USD
市值
股價為何變動
As of Aug 17, 2026, PBYI was little changed and closed at $8.82. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Puma Biotechnology is an oncology company focused on breast-cancer therapy and targeted cancer medicines. Its business has long centered on a concentrated commercial oncology franchise.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Puma sits in specialty oncology biotechnology.
商業模式特徵
The company depends on product revenue, market access, and the durability of its commercial cancer portfolio.
生技產業定位
Puma is a commercial oncology name with limited breadth but meaningful sensitivity to product execution.
未來催化劑
- Puma Biotechnology’s catalysts are NERLYNX execution and any label / oncology update that extends the franchise. Investors will care about whether the commercial base can keep hanging on.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。